ENTX Receives FDA Feedback
Entera Bio receives FDA's positive feedback for its Phase 3 registrational protocol for EB613 tablet to treat osteoporosis
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.